HIV RNA Viral Load (Qualitative Nucleic Acid Probe)
This test detects the amount of HIV genetic material (RNA) in your blood to monitor disease progression and treatment response.
["Helps track how well your HIV treatment is working by measuring viral load levels."]
Key facts at a glance
- LOINC
- 86548-5
- Short code
- HIV 2 RNA # Plas NAA+probe
- Synonyms
- HIV 2 RNA # Plas NAA+probe
- Category
- chemistry
- Sample
- plasma
- Container
- Lavender-top (EDTA) or Green-top (Heparin)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- probe-amp-tar
- CPT
- 86701
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What the Test Measures
The HIV RNA probe test looks for HIV genetic material (RNA) in a blood sample. It uses a specialized probe to identify and quantify the virus’s presence, helping doctors determine if your viral load is suppressed by treatment or if it’s increasing.
Why It’s Done
Your healthcare provider may order this test if you’re newly diagnosed with HIV, during treatment to check for resistance or treatment failure, or to monitor ongoing viral load levels. It’s also used in clinical trials or research settings.
Sample Collection and Preparation
A blood sample is drawn from your arm, typically sent to a lab for processing. The lab extracts viral RNA from your blood and applies the probe to detect and measure the virus’s genetic material.
Test Results and Interpretation
Results are reported as a qualitative (positive/negative) detection of HIV RNA. A positive result means the virus is present, while a negative result indicates no detectable viral load. Interpretation depends on clinical context, such as treatment history or symptoms.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
HIV RNA Probe Test
Frequently asked questions
This test is crucial for managing HIV because it provides real-time data on viral activity. Low viral loads (often undetectable) correlate with effective treatment and reduced risk of HIV-related complications. Persistently high viral loads may signal treatment resistance or non-compliance.
Your healthcare provider will determine the frequency based on your treatment plan. Typically, tests are done every 3–6 months for stable patients on effective therapy, but this can vary. Follow-up may be more frequent if you’re newly diagnosed or experiencing treatment changes.
A qualitative result simply tells you whether HIV RNA is present (positive) or not (negative). It doesn’t provide a specific number of viral copies. In contrast, a quantitative test measures the exact amount of virus in your blood, often used to monitor treatment effectiveness more precisely.
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy